What management strategies are recommended for a patient with Bechet's disease, taking 150mg Imuran (azathioprine) and 6mg prednisone daily, who contracts influenza or COVID-19?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Behçet's Disease Patients on Imuran and Prednisone with Influenza or COVID-19

Continue both azathioprine (Imuran) 150mg and prednisone 6mg during influenza or COVID-19 infection, as this low-dose steroid regimen does not require treatment interruption and azathioprine shows no evidence of worsening viral outcomes.

Medication Management During Active Infection

Azathioprine (Imuran) - Continue Treatment

  • Do not stop azathioprine during influenza or COVID-19 infection 1
  • There is no current evidence that azathioprine increases the risk of COVID-19 infection or complications 1
  • Stopping immunosuppression abruptly risks Behçet's disease flare, which could require higher-dose steroids or hospitalization—a worse outcome than continuing therapy 1
  • Immunosuppressive effects persist for weeks to months after cessation, so stopping provides no immediate protective benefit 1

Prednisone 6mg Daily - Continue at Current Dose

  • Your 6mg daily dose is below the high-risk threshold and should be continued unchanged 1
  • The critical concern is prednisolone doses ≥20mg daily, which significantly increase risk of respiratory tract infection, opportunistic infection, and septicemia 1
  • Patients on ≥20mg daily require enhanced shielding precautions, but this does not apply to your 6mg dose 1
  • Never stop corticosteroids suddenly without medical advice—this can precipitate adrenal crisis 1

Supportive Care and Monitoring

Immediate Actions

  • Contact your healthcare provider to report the infection and confirm the plan to continue medications 1
  • Monitor for worsening respiratory symptoms, high fever, or signs of Behçet's flare 2
  • Ensure adequate hydration and rest 2

COVID-19 Specific Considerations

  • You are eligible for antiviral treatment (Paxlovid) if diagnosed within 5 days of symptom onset 3
  • Paxlovid can be safely administered with azathioprine and low-dose prednisone, though drug interaction review is mandatory 3
  • Initiate treatment as soon as possible after COVID-19 diagnosis for maximum benefit 3

Behçet's Disease Monitoring

  • In 74% of Behçet's patients with COVID-19, disease activity remained unchanged during infection 2
  • Rarely, COVID-19 can trigger Behçet's flare (seen in case reports), requiring temporary steroid increase 4
  • If you develop new oral ulcers, skin lesions, joint pain, or eye symptoms during infection, contact your rheumatologist immediately 4

Evidence-Based Reassurance

Risk Profile in Behçet's Patients

  • Behçet's patients on immunosuppression do not show higher COVID-19 incidence than the general population (0.69% prevalence in one cohort) 2
  • They demonstrate milder disease with lower morbidity and mortality rates compared to general population expectations 2
  • In a series of 59 Behçet's patients with COVID-19, only 25.4% required hospitalization and mortality was 1.7% 2
  • Most patients were on immunosuppressive drugs at time of infection without adverse outcomes 2

Treatment Continuation Data

  • A retrospective study of 54 Behçet's patients during the pandemic showed 44 (81%) continued previous treatment unchanged with no life-threatening activations and zero COVID-19 cases 5
  • Expert consensus supports continuing colchicine and immunosuppressive agents in Behçet's patients without confirmed COVID-19 6

Critical Pitfalls to Avoid

  • Do not stop azathioprine out of fear—the risk of disease flare requiring high-dose steroids outweighs theoretical infection concerns 1
  • Do not abruptly discontinue prednisone—even at 6mg daily, sudden cessation risks adrenal insufficiency 1
  • Do not delay seeking medical attention if you develop severe symptoms (difficulty breathing, chest pain, confusion, inability to stay awake) 2
  • Do not assume you need to stop medications before contacting your doctor—the default is continuation unless specifically advised otherwise 1, 6

When to Temporarily Hold Medications

The only scenario requiring medication interruption would be:

  • Severe COVID-19 requiring ICU admission with multiorgan failure (decision made by treating intensivist) 1
  • Development of severe drug-related toxicity (profound lymphopenia, severe hepatotoxicity) 7
  • Specific instruction from your rheumatologist based on individual clinical deterioration 6

These decisions must be made by your treating physicians, not preemptively by you 1, 6.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

7
Guideline

Management of 6-Mercaptopurine Related Toxicity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is 6mg of prednisone sufficient to control Behçet's disease in a patient who requires temporary cessation of azathioprine (Imuran) due to COVID-19?
What is the recommendation for continuing Imuran (azathioprine) at 150mg daily in a patient with Behçet's disease who contracts COVID-19?
What can a patient with Behçet's disease, taking Imuran (azathioprine) and prednisone, take for fever and body ache if they contract influenza or COVID-19?
What is the management approach for a patient with Bechets disease on Imuran (azathioprine) and low-dose prednisone presenting with elevated Red Cell Distribution Width (RDW)?
Is it safe to reintroduce Imuran (azathioprine) at a lower dose in a patient with Bechet's disease who experienced moderate hepatocellular liver injury with elevated alanine transaminase (ALT) and aspartate transaminase (AST) that normalized after a 2-week break?
Can a patient stop taking statins (HMG-CoA reductase inhibitors) like atorvastatin (Lipitor), simvastatin (Zocor), or rosuvastatin (Crestor) cold turkey or do they need to wean off the medication?
What is the recommended frequency of administration for oxycodone (opioid analgesic) 5mg in a patient requiring pain management?
What is the most effective way to decrease the risk of stroke in a patient with severe Rheumatic (Rheumatoid) mitral regurgitation and Atrial Fibrillation (A fib)?
Is a patient with mild to moderate 50-60% proximal right Internal Carotid Artery (ICA) stenosis, mild up to 50% left ICA stenosis, and moderate stenosis in the left subclavian artery a contraindication to proceeding with surgical Aortic Valve Replacement (SAVR)?
What over-the-counter (OTC) treatments are available for a female experiencing vaginal pain?
Should a 34-year-old female with a history of severe right club foot deformity, bilateral foot pain, and previous surgeries be approved for custom foot orthoses (CFOs) despite her certificate of coverage excluding foot orthotics not attached to a medically necessary custom brace or prescribed as part of post-surgical or post-traumatic casting care?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question